Last reviewed · How we verify

HAART containing nevirapine

The HIV Netherlands Australia Thailand Research Collaboration · Phase 2 active Small molecule

HAART containing nevirapine is a Non-nucleoside reverse transcriptase inhibitor Small molecule drug developed by The HIV Netherlands Australia Thailand Research Collaboration. It is currently in Phase 2 development for HIV-1 infection.

Non-nucleoside reverse transcriptase inhibitor

Non-nucleoside reverse transcriptase inhibitor Used for HIV-1 infection.

At a glance

Generic nameHAART containing nevirapine
SponsorThe HIV Netherlands Australia Thailand Research Collaboration
Drug classNon-nucleoside reverse transcriptase inhibitor
TargetReverse transcriptase
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhasePhase 2

Mechanism of action

Nevirapine works by inhibiting the activity of reverse transcriptase, an enzyme that HIV uses to replicate its genetic material.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about HAART containing nevirapine

What is HAART containing nevirapine?

HAART containing nevirapine is a Non-nucleoside reverse transcriptase inhibitor drug developed by The HIV Netherlands Australia Thailand Research Collaboration, indicated for HIV-1 infection.

How does HAART containing nevirapine work?

Non-nucleoside reverse transcriptase inhibitor

What is HAART containing nevirapine used for?

HAART containing nevirapine is indicated for HIV-1 infection.

Who makes HAART containing nevirapine?

HAART containing nevirapine is developed by The HIV Netherlands Australia Thailand Research Collaboration (see full The HIV Netherlands Australia Thailand Research Collaboration pipeline at /company/the-hiv-netherlands-australia-thailand-research-collaboration).

What drug class is HAART containing nevirapine in?

HAART containing nevirapine belongs to the Non-nucleoside reverse transcriptase inhibitor class. See all Non-nucleoside reverse transcriptase inhibitor drugs at /class/non-nucleoside-reverse-transcriptase-inhibitor.

What development phase is HAART containing nevirapine in?

HAART containing nevirapine is in Phase 2.

What are the side effects of HAART containing nevirapine?

Common side effects of HAART containing nevirapine include Rash, Nausea, Fatigue.

What does HAART containing nevirapine target?

HAART containing nevirapine targets Reverse transcriptase and is a Non-nucleoside reverse transcriptase inhibitor.

Related